LY-272,015

LY-272,015
臨床資料
其他名稱	LY-272,015; 1-[(3,4-Dimethoxyphenyl)methy]-2,3,4,9-tetrahydro-6-methyl-1H-pyrido[3,4-b]indole
識別資訊
	IUPAC命名法 1-(3,4-dimethoxybenzyl)-6-methyl-2,3,4,9-tetrahydro-1H-β-carboline; ;
CAS號	172895-15-7
PubChem CID	9929424;
ChemSpider	8105055;
UNII	5NV3JP3GP6;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID30432996、DTXSID701336801 ;
化學資訊
化學式	C21H24N2O2
摩爾質量	336.44 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES c4cc(C)cc3c4[nH]c2c3CCNC2Cc(cc1OC)ccc1OC;
	InChI InChI=1S/C21H24N2O2/c1-13-4-6-17-16(10-13)15-8-9-22-18(21(15)23-17)11-14-5-7-19(24-2)20(12-14)25-3/h4-7,10,12,18,22-23H,8-9,11H2,1-3H3; Key:GDAJGLDMCDMPIR-UHFFFAOYSA-N;

參考文獻

^ Watts SW, Fink GD. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats. The American Journal of Physiology. March 1999, 276 (3): H944–52. PMID 10070078. S2CID 13301249. doi:10.1152/ajpheart.1999.276.3.H944.
^ Russell A, Banes A, Berlin H, Fink GD, Watts SW. 5-Hydroxytryptamine(2B) receptor function is enhanced in the N(omega)-nitro-L-arginine hypertensive rat. The Journal of Pharmacology and Experimental Therapeutics. October 2002, 303 (1): 179–87. PMID 12235249. S2CID 98055109. doi:10.1124/jpet.102.037390.